Related references
Note: Only part of the references are listed.Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization
Ahmed K. Ghamraoui et al.
JOURNAL OF VASCULAR SURGERY (2021)
Protamine use in transfemoral carotid artery stenting is not associated with an increased risk of thromboembolic events
Patric Liang et al.
JOURNAL OF VASCULAR SURGERY (2021)
Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment
Alicja Krakowiak et al.
CLINICAL MEDICINE INSIGHTS-CASE REPORTS (2020)
Mechanism of Procedural Stroke Following Carotid Endarterectomy or Carotid Artery Stenting Within the International Carotid Stenting Study (ICSS) Randomised Trial
A. Huibers et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2015)
Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?
Grant C. Sorkin et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2014)
Protamine Does Not Increase Risk of Stroke in Patients With Elective Carotid Stenting
Jennifer S. McDonald et al.
STROKE (2013)
The Influence of Anti-Platelet Resistance on the Development of Cerebral Ischemic Lesion after Carotid Artery Stenting
Tae-Jin Song et al.
YONSEI MEDICAL JOURNAL (2013)
Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: Executive summary
John J. Ricotta et al.
JOURNAL OF VASCULAR SURGERY (2011)
Predictors of Neurological Events Associated With Carotid Artery Stenting in High-Surgical-Risk Patients Insights From the Cordis Carotid Stent Collaborative
Herbert D. Aronow et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Measurement of Antiplatelet Inhibition during Neurointerventional Procedures: The Effect of Antithrombotic Duration and Loading Dose
D. J. Pandya et al.
JOURNAL OF NEUROIMAGING (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology
Wiktor Kuliczkowski et al.
EUROPEAN HEART JOURNAL (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis:: a double-blind comparison to clopidogrel with aspirin
S Husted et al.
EUROPEAN HEART JOURNAL (2006)
Share Paper
